Last reviewed · How we verify
BB3008 tablet
At a glance
| Generic name | BB3008 tablet |
|---|---|
| Also known as | BB3008 |
| Sponsor | Broadenbio Ltd., Co. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BB3008 tablet CI brief — competitive landscape report
- BB3008 tablet updates RSS · CI watch RSS
- Broadenbio Ltd., Co. portfolio CI